MedTrace Logo

JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders

NCT00873574 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 234

Last updated 2013-03-08

No results posted yet for this study

Summary

The main goal of the study is to progress in our understanding of the molecular basis of myeloproliferative disorders of the bone marrow (polycythemia vera, essential thrombocythemia, primary myelofibrosis). The study will focus on the genes encoding factors implicated in the JAK-STAT pathway which has an essential role in these diseases

Conditions

  • Myeloproliferative Disorders

Interventions

BIOLOGICAL

Blood samples and buccal swabs

Peripheral blood samples (35 ml) and buccal swabs

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Albert NAJMAN, MD PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2011-05-31
Completion
2012-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00873574 on ClinicalTrials.gov